Literature DB >> 6122588

Differentiation of potent mu and kappa-opiate agonists using heat and pressure antinociceptive profiles and combined potency analysis.

N Upton, R D Sewell, P S Spencer.   

Abstract

The antinociceptive profiles of strong mu- and kappa-opiate agonists were determined in the tail clip, hot plate (55 degrees C) and tail immersion (48 degrees C and 55 degrees C) tests in mice. All mu- and kappa-agonists produced steep dose-response lines in all the tests. Using a combined analysis of potencies for pressure against heat noxia it was possible to differentiate between mu- and kappa-agonists and this paralleled findings in other laboratories using isolated tissue preparations. It was also concluded that qualitative rather than quantitative differences between noxia were responsible for the observed differentiation since potency differences for mu- and kappa-agonists between tests were maintained even after the intensity of heat and pressure noxia were equated. It was also proposed that use of the combined tail clip and immersion tests may be useful for rapid behavioural classification of novel synthetic mu- and kappa-opiate analgesics.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6122588     DOI: 10.1016/0014-2999(82)90484-8

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  9 in total

1.  Dynorphin A decreases voltage-dependent calcium conductance of mouse dorsal root ganglion neurones.

Authors:  R L Macdonald; M A Werz
Journal:  J Physiol       Date:  1986-08       Impact factor: 5.182

2.  Analgesic activity of a novel bivalent opioid peptide compared to morphine via different routes of administration.

Authors:  B S Silbert; A W Lipkowski; M S Cepeda; S K Szyfelbein; P F Osgood; D B Carr
Journal:  Agents Actions       Date:  1991-07

Review 3.  Sufentanil. A review of its pharmacological properties and therapeutic use.

Authors:  J P Monk; R Beresford; A Ward
Journal:  Drugs       Date:  1988-09       Impact factor: 9.546

4.  Differential sensitivity of models of antinociception in the rat, mouse and guinea-pig to mu- and kappa-opioid receptor agonists.

Authors:  A G Hayes; M J Sheehan; M B Tyers
Journal:  Br J Pharmacol       Date:  1987-08       Impact factor: 8.739

Review 5.  Opioid agonist-antagonist drugs in acute and chronic pain states.

Authors:  P J Hoskin; G W Hanks
Journal:  Drugs       Date:  1991-03       Impact factor: 9.546

Review 6.  Sex differences in kappa opioid pharmacology.

Authors:  Khampaseuth Rasakham; Lee-Yuan Liu-Chen
Journal:  Life Sci       Date:  2010-10-14       Impact factor: 5.037

7.  Spinal antinociceptive actions of mu- and kappa-opioids: the importance of stimulus intensity in determining 'selectivity' between reflexes to different modalities of noxious stimulus.

Authors:  C G Parsons; P M Headley
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

8.  Standardization of the rat paw formalin test for the evaluation of analgesics.

Authors:  H Wheeler-Aceto; A Cowan
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

9.  Characterization of the opiate receptor population mediating inhibition of VIP-induced secretion from the small intestine of the rat.

Authors:  I M Coupar
Journal:  Br J Pharmacol       Date:  1983-10       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.